All lobbying filings
THE KPM GROUP DC LLC
THE KPM GROUP DC LLC filed a Q2 amendment for SOLENO THERAPEUTICS, INC. on July 28, 2026, reporting $10,000 in lobbying income.
Lobbying for SOLENO THERAPEUTICS, INC. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.
Filing · LD-2 quarterly report
Q2 amendment
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 28, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
California
Government bodies contacted
2
Lobbying activity
1
HR 5509/S.2903 Safe Step Act HR 6423/S. 864 HELP Copays Act